Sign in
8-K

Current Report

CytomX Therapeutics, Inc. Filed Acc 0001193125-22-250137

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d401274d8k.htm…